in light of experimental data showing that the oral administration of tyrosine , precursor of the catecholamine series of neurotransmitters , can increase brain norepinephrine concentrations and activity , we have conducted preliminary trials of tyrosine in depressed outpatients .
C0006104
brain
C0004927
conducted